CAVE CREEK, AZ, July 31, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, announced today that it has successfully uplisted from the OTC® Pink Market to the OTCQB® Venture Market (“OTCQB”). The uplisting was processed and approved by OTC Markets Group Inc., and the Company began trading on OTCQB® July 31, 2023. Endexx® Corporation will continue to trade under the ticker symbol “EDXC”. The OTCQB® Venture Market offers investors transparent trading in entrepreneurial and development stage U.S. and international companies that may not yet qualify for OTCQX®. To be eligible, companies must be current in their reporting and must undergo an annual verification and management certification process.

“This is a significant milestone supporting the accelerated growth of Endexx® with our uplisting to the OTCQB® Venture Market,” said Davis. “This move reflects our commitment to enhancing transparency, increasing market visibility, and providing enhanced opportunities for our shareholders. Uplisting to the OTCQB® will allow us to access a broader investor base, attract institutional investors, and improve liquidity for our stock. This action demonstrates our continued growth and solidifies our position as a trusted player in the plant based consumer products and alternative vape industries.”

www.endexx.com & www.cbdunlimited.com

www.tryhyla.com

About Endexx® Corporation

Endexx® Corporation develops and distributes all natural, plant-derived wellness products and topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.com

Hyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 11 states and 10 countries and has signed distribution agreements with an additional nine countries The Hyla vape products bear the Underwriters Laboratories global safety certification and is CE approved.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

No Offer or Solicitation. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and, where applicable, the requirements under the securities laws of any other applicable jurisdiction.

For further information, please contact:

Endexx Corporation
IR@Endexx.com
480-595-6900

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

• Uplists from the OTC Pink Market to the OTCQB Venture Market; continues trading under ticker HLCO
• Secures up to $7M in new funding from strategic partners including billion-dollar investment office of the Burman family (New Delhi) and the Goetz Family Office (Munich)
• Including previously announced financing, brings total raised and committed equity funding  to up to $17M, alongside the $150M credit facility supporting future acquisitions

NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) — The Healing Company (OTCQB: HLCO) (“The Healing Company” or the “Company”), today announced that it has successfully uplisted from the OTC Pink Market to the OTCQB Venture Market (“OTCQB”) and will continue trading under the symbol “HLCO”. Additionally, The Healing Company announced it had secured up to $7 million in new investment from strategic partners including the investment office of the Burman family, majority shareholders of one of the largest Indian consumer packaged goods (CPG) companies and the largest Ayurvedic company worldwide with a $12 billion market capitalization, as well as the esteemed German family office of Stephan and Ingvild Goetz (Munich). Including previously announced financing, this brings total raised and committed equity funding to up to $17 million, alongside the $150 million credit facility supporting future acquisitions.

The investment is intended to support the Company’s strategy of building a community of powerful healing brands through the acquisition of companies in the wellness, supplement, and nutraceutical spaces. Trading on the OTCQB Venture Market provides The Healing Company’s current and future investors with greater access to data, home country disclosure, ease of trading, and transparency. With the new funding and successful uplisting, The Healing Company is aiming for a NASDAQ listing within the next 12 months.

“The announcement of the uplisting, alongside the funding from long-term strategic investors experienced in the wellness, supplement, and nutraceutical sectors, is further validation of our business model and will support an acceleration of our accretive buy-and-build strategy. Moreover, we are confident the uplist will allow us to reach a broader investor base, and is an important stepping stone towards our goal of listing on a national exchange in the near-term. These are all exciting milestones for The Healing Company as we continue to acquire and scale health and wellbeing businesses to further our mission of bringing integrated healing to the world,” said Simon Belsham, CEO and Co-Founder of The Healing Company.

Mr. Belsham further noted, “This announcement comes on the heels of record financial performance during the fiscal third quarter, in which we achieved sequential revenue of $3.2 million, a 34% increase over the second quarter, resulting from our successful track record of acquiring and integrating complementary businesses. Your Super, our first acquisition, demonstrated profitable growth this quarter for the first time in its history. Building on this success, in March we completed the acquisition of the Chopra Global wellbeing experiences businesses which include Chopra’s physical product line, the Chopra meditation & wellbeing app, as well as licensed experiences including the award-winning Chopra Health Retreat at CIVANA Wellness Resort & Spa and the Chopra Mind-Body Zone and Spa at the Lake Nona Performance Club. Importantly, we are already seeing strong performance from the Chopra businesses. Looking ahead, we have a robust pipeline of additional acquisition targets that we believe would be both synergistic and accretive.”

The OTCQB, operated by OTC Markets Group Inc., is the premier marketplace for early-stage and developing U.S. and international companies that are committed to providing a high-quality trading and information experience for their U.S. investors. Companies must be current in their financial reporting to undergo an annual verification and management certification process, including meeting a minimum bid price and other financial conditions. The OTCQB quality standards provide a strong baseline of transparency as well as the technology and regulation to improve the information and trading experience for investors. The OTCQB is recognized by the Securities and Exchange Commission as an established public market providing public information for analysis and value of securities. Investors can find real-time quote and market information for the Company, once listed, at https://www.otcmarkets.com.

About The Healing Company

The Healing Company Inc. was founded with a bold aim: Bring integrated healing to the world. Compelled by the global healthcare crisis and a deep belief in a different way—one which draws on conventional medicine and ancient wisdom, science and nature—the company looks to democratize access to integrated healing methods, while helping the world evolve how it thinks about health and healthcare. To do so, the company is building a community of powerful healing brands, identifying, acquiring, and helping scale the reach and impact of the world’s highest potential healing practices & products.

The Healing Company’s common stock is quoted for trading on the OTCQB under the symbol HLCO, and its investors and advisors include global wellbeing icon Dr. Deepak Chopra, MD, renowned investor and psychedelics entrepreneur Christian Angermayer, and Social Chain & Thirdweb founder and Dragons Den member Steven Bartlett. For more information, visit http://www.healingcompany.com.

Forward-looking statements

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financial requirements, business strategy, products and services, potential future financings, acquisition and scaling of future brands and or project and its anticipated financing plans, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements.  Such forward-looking statements are estimates reflecting the Company’ s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements; foreign exchange and other financial markets; changes in the interest rates on borrowings; hedging activities; changes costs of goods; changes in the investments and expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which The Healing Company operates. There can be no assurance that The Healing Company will achieve the above stated brand acquisitions and scaling of those brands or the closing of any required financing. The reader should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by The Healing Company from time to time with the Securities and Exchange Commission.

Investor Relations:
Crescendo Communications, LLC
Tel: (212) 671-1020
Email: hlco@crescendo-ir.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

SANTA BARBARA, Calif., March 15, 2022 /PRNewswire/ — Bloomios, Inc. (OTCQB: BLMS), a leading researcher, manufacturer and wholesaler of hemp-derived cannabinoid nutraceuticals and cosmetics, will begin trading on the OTCQB® Venture Market under the symbol, BLMS, at the opening of the market today.

Over the course of the past year, Bloomios has rapidly emerged as a premier manufacturer of private- and white-label hemp-derived cannabinoid products. This includes nutraceuticals and cosmetics that incorporate cannabidiol (CBD), the most popular cannabinoid of the more than 100 distinct cannabinoids that can be derived from hemp.

Bloomios also produces products featuring such alternative cannabinoids and peripheral components of hemp which share similar health benefits with CBD, like cannabigerol (CBG) for pain management and cannabinol (CBN) for sleep, as well as terpenes (or flavonoids) that create a beneficial entourage effect for the user.

Since Bloomios’ official launch in the fourth quarter of 2020, gross revenues have climbed from virtually zero to total more than $8 million by September 30, 2021, with demand exceeding supply.

Following a facility expansion and equipment upgrade, Bloomios has increased its production capacity by an estimated 300%. Bloomios products are now being distributed by hundreds of corporate customers across the U.S.

“As a fully-reporting, emerging growth company, our listing on the OTCQB greatly elevates our profile in the market, provides greater liquidity and helps broaden our shareholder base,” stated Bloomios CEO, Michael Hill. “The listing represents a major step in our long-term capital market strategy designed to build shareholder value and leverage our unique B2B value proposition in the fast-growing hemp-derived products space.”

Bloomios is targeting a North American CBD market that is projected to grow at a 33.3% compounded annual growth rate (CAGR) to reach $61.3 billion by 2027, with the market for alternative cannabinoids expected to grow at 20.1% CAGR to hit $26.2 billion by 2028.

The company is also looking to further expand into the high-margin nutraceuticals space that is also seeing tremendous growth, and it is currently evaluating several accretive M&A targets.

For more information about the company, go to bloomios.com or contact Ron Both or Justin Lumley at (949) 432-7557 or [email protected].

About Bloomios
Bloomios, Inc. researches, manufactures, markets and distributes U.S. hemp-derived cannabinoid supplements and cosmetic products through wholesale distribution channels and its wholly owned subsidiary, Bloomios Private Label. The company provides custom formulation, brand development, manufacturing and order fulfillment to a wide variety of customers, including small and major brands, chain stores, vape shops and distributors. It offers private- and white-label customers a collection of more than 200 customizable hemp products across 12 categories.

Bloomios is headquartered in Santa Barbara, California, with manufacturing and distribution in Daytona Beach, Florida.

To learn more, visitbloomios.com.

Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the sales of the company’s identity protection software products into various channels and market sectors, the issuance of the Company’s pending patent applications, COVID-19, and the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the company.

Investor Relations Contact:
Ronald Both or Justin Lumley
CMA Investor Relations
Tel (949) 432-7566
Email contact

Media Contact:
Tim Randall
CMA Media Relations
Tel (949) 432-7572
Email Contact

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.